Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot
Code deleted, see 43754, 43755.

Official Description

Gastric analysis test with injection of stimulant of gastric secretion (eg, histamine, insulin, pentagastrin, calcium and secretin)

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 91052 refers to a gastric analysis test that involves the injection of a stimulant to assess gastric secretion. This procedure is commonly known as the Hollander Test. It is utilized to evaluate the acidity levels within the stomach, which can provide critical insights into various gastrointestinal conditions, including the likelihood of ulcer recurrence. During the test, gastric contents are extracted through a tube that is carefully inserted through the patient's nose or mouth. This method allows for a thorough analysis of the stomach's secretions, which is essential for diagnosing and managing conditions related to gastric function. The use of stimulants such as histamine, insulin, pentagastrin, calcium, and secretin during the test enhances the accuracy of the results by provoking gastric secretion, thereby enabling healthcare professionals to obtain a comprehensive understanding of the patient's gastric health.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The gastric analysis test with the injection of a stimulant is indicated for various clinical scenarios where assessment of gastric function is necessary. The following conditions may warrant this procedure:

  • Assessment of Gastric Acidity This test is performed to evaluate the acidity levels in the stomach, which can be crucial for diagnosing conditions such as gastritis or peptic ulcers.
  • Ulcer Recurrence Evaluation The procedure helps in determining the chances of ulcer recurrence, providing valuable information for ongoing patient management and treatment planning.
  • Gastric Secretion Disorders It is indicated for patients suspected of having disorders related to gastric secretion, which can affect digestion and overall gastrointestinal health.

2. Procedure

The gastric analysis test with stimulant injection involves several key procedural steps to ensure accurate results. Each step is critical for the successful completion of the test:

  • Preparation of the Patient Prior to the procedure, the patient is typically instructed to fast for a specified period to ensure that the stomach is empty. This fasting period is essential for obtaining accurate gastric secretion measurements.
  • Insertion of the Tube A thin, flexible tube is carefully inserted through the patient's nose or mouth and advanced into the stomach. This tube, often referred to as a nasogastric tube, allows for the suctioning of gastric contents for analysis.
  • Injection of Stimulant Once the tube is in place, a stimulant such as histamine, insulin, pentagastrin, calcium, or secretin is injected. This stimulant provokes gastric secretion, which is necessary for the analysis of gastric contents.
  • Collection of Gastric Contents After the injection, gastric contents are suctioned through the tube. This collected material is then analyzed for various parameters, including acidity levels and the presence of digestive enzymes.
  • Monitoring and Documentation Throughout the procedure, the patient's vital signs and overall condition are monitored. Detailed documentation of the procedure, including the type of stimulant used and the volume of gastric contents collected, is essential for accurate coding and billing.

3. Post-Procedure

After the gastric analysis test is completed, the patient may be monitored for a short period to ensure there are no immediate adverse reactions to the stimulant injection. It is important to provide the patient with post-procedure care instructions, which may include dietary recommendations and signs of potential complications to watch for. The results of the gastric analysis will be compiled and interpreted by the healthcare provider, who will discuss the findings with the patient and determine any necessary follow-up actions or treatments based on the results.

Short Descr GASTRIC ANALYSIS TEST
Medium Descr GA TST NJX STIMULANT GSTR SECRETION
Long Descr Gastric analysis test with injection of stimulant of gastric secretion (eg, histamine, insulin, pentagastrin, calcium and secretin)
Status Code Active Code
Global Days 000 - Endoscopic or Minor Procedure
PC/TC Indicator (26, TC) 1 - Diagnostic Tests for Radiology Services
Multiple Procedures (51) 0 - No payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 0 - Payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Ancillary Services
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T2D - Other tests - other
MUE Not applicable/unspecified.
CCS Clinical Classification 97 - Other gastrointestinal diagnostic procedures
Date
Action
Notes
2011-01-01 Deleted Code deleted, see 43754, 43755.
Pre-1990 Added Code added.
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"